Abstract:Objective To observe the relationship between cortisol, electroencephalogram (EEG) and cognitive function in young patients with first-episode depression. Methods From January 2018 to June 2019, 46 patients with first-episode depression in the outpatient clinic of Ningbo Kangning Hospital (“our hospital” for short) were selected as the study subjects. According to the average cortisol level (557 nmol/L), they were divided into low cortisol group (18 cases, cortisol ≤557nmol/L) and high cortisol group (28 cases, cortisol >557 nmol/L). The general data, wechsler memory scale (WMS) score and EEG data of all patients were collected,and the difference at different cortisol levels were analyzed. The correlation between WMS score, abnormal EEG performance and cortisol levels were analyzed. Results There were no significant difference in general clinical data (age, sex, body fat ratio, education level) between low cortisol group and high cortisol group (P > 0.05). The average score and classification of WMS in the low cortisol group were higher than those in the high cortisol group, and the differences were statistically significant (P < 0.05). The incidence of abnormal EEG performance (θ wave, δ wave, frontotemporal spike wave, frontotemporal cusp wave, fast-slow combined wave, epileptiform discharge wave) in the low cortisol group was lower than that in the high cortisol group. Abnormalities in EEG were positively correlated with the cortisol level (r = 0.786, 0.627, 0.774, 0.784, 0.681, 0.735, P < 0.05). The WMS score was negatively correlated with the cortisol level (r = -0.816, P < 0.05). Conclusion There are changes in cognitive function in the first-onset young patients with depression. The main manifestations of EEG abnormalities are widespread slow wave, 14-20 HZ fast wave, and epileptiform discharge wave. Changes in cognitive function and the degree of EEG abnormalities are related to cortisol levels, which deserves clinical attention.
[1] 王赟,崔少娟,范晨晓,等.缓解期抑郁症患者最后通牒博弈中的社会决策行为[J].中国心理卫生杂志,2019,14(11):801-806.
[2] 刘代焱,王尧,胡先玲,等.青年中期人群首发重度抑郁障碍弥散张量成像研究[J].第三军医大学学报,2019,41(18):1807-1814.
[3] 李红丽,王飞.阿戈美拉汀与舍曲林治疗首发抑郁症的疗效比较[J].慢性病学杂志,2019,20(8):1192-1193.
[4] 周勤,赵后锋,耿德勤,等.舍曲林对儿童青少年抑郁症首发患者血清超敏C反应蛋白水平的影响[J].临床医药文献电子杂志,2018,5(72):6-7.
[5] Stahl SM. The last Diagnostic and Statistical Manual(DSM):replacing our symptom-based diagnoses with a brain circuit-based classification of mental illnesses [J]. CNS Spectr,2013,18(2):65-68.
[6] Lin CH,Park C,Mcintyre RS. Early improvement in HAMD-17 and HAMD-7 scores predict response and remission in depressed patients treated with fluoxetine or electroconvulsive therapy [J]. J Affect Disord,2019,253:154-161.
[7] 邰传朕,鲍纪雪,许秀峰,等.首发抑郁症患者认知功能的影响因素[J].中国心理卫生杂志,2018,32(10):808-815.
[8] 冯静雯,赖虹宇,邓伟,等.精神分裂症和抑郁症患者静息态脑电功率谱熵的对照研究[J].中国生物医学工程学报,2019,38(4):385-391.
[9] Bruk GW,Yousef TB. Antidepressant effects of moxidectin,an antiparasitic drug,in a rat model of depression [J]. Behav Brain Res,2019,3(76):1840-1844.
[10] 韩妍.米氮平、舍曲林治疗首发抑郁症的价值分析[J].中国现代药物应用,2019,13(15):133-134.
[11] 郭蕾,包爱民.双向障碍中糖皮质激素对下丘脑-垂体-肾上腺轴活性的负反馈调节[J].重庆医科大学学报,2019, 44(4):493-500.
[12] 李欣,薛坤喜,万静,等.伴抑郁症状的首发精神分裂症患者血清皮质醇水平的相关研究[J].数理医药学杂志,2016,29(7):1019-1020.
[13] Kyosuke UN,Hajime MH,Kengo SD,et al. Vulnerability to depressive behavior induced by overexpression of striatal Shati/Nat8l via the serotonergic neuronal pathway in mice [J]. Behav Brain Res,2019,12(9):1076-1084.
[14] Jorge MA. Circadian insights into the biology of depression:Symptoms,treatments and animal models [J]. Behav Brain Res,2019,20(13):2191-2194.
[15] 陈彬彬,吕海燕,徐象珍,等.抑郁症患者自杀风险与下丘脑-垂体-肾上腺轴功能的研究[J].中国卫生标准管理,2019,10(1):35-37.
[16] 吴晓.自我效能感在帕金森患者康复护理中的临床研究[J].中国卫生标准管理,2019,10(3):112-115.
[17] 闫志芳,谢雯,蔡春岚,等.首发和复发性抑郁症治疗前后认知功能及其相关因素分析[J].国际精神病学杂志,2019,46(4):652-655.
[18] 韩佳硕.抑郁人群睡眠脑电特征研究[D].兰州:兰州大学,2019.
[19] 从恩朝,蔡亦蕴,陈海莹,等.青少年抑郁情绪与心理弹性、家庭环境因素的关联[J].中国医药导报,2019,16(17):31-34.
[20] 李鹏,王长明,李峰,等.早发抑郁患者功能磁共振成像对下脑区静息态自发活动与疾病严重程度的相关性研究[J].中国医学装备,2018,15(6):61-66.
[21] 宫媛,胡小芳,赵锦成,等.经颅磁刺激结合阿戈美拉汀治疗难治性抑郁症的临床效果[J].中国医药,2018,13(2):274-277.
[22] Getachew BK,Tizabi YU. Antidepressant effects of moxidectin,an antiparasitic drug,in a rat model of depression [J]. Behav Brain Res,2019,3(6):998-1004.
[23] Kim JH,Joo YH,Son YD,et al. In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-na?觙ve young adults with major depression [J]. Eur Neuropsychopharmacol,2019,29(2):278-290.
[24] 安文军,李金花,王和平,等.儿童青少年抑郁症的脑电及影像学研究进展[J].中国康复理论与实践,2019,25(3):314-318.
[25] 徐秀梅,王婷,郭渠莲,等.振幅整合脑电图对非创伤性意识障碍患儿预后的预测价值[J].成都医学院学报,2019,14(3):354-358.
[26] Mendoza JG. Circadian insights into the biology of depression:Symptoms,treatments and animal models [J]. Behav Brain Res,2019,28(6):4219-4226.